Skip to main content
. 2022 Jul 11;9:890108. doi: 10.3389/fcvm.2022.890108

Table 2.

Future areas of study in the management of advanced heart failure in women.

Areas of equipoise in the management of advanced heart failure in women Potential areas of future research
Hemodynamic instability Identify sex-specific cutoffs that indicate hemodynamic compromise in men and women
Biomarker derangements Explore the validity of sex-specific cutoffs for advanced heart failure prognostication
Exercise capacity Investigate sex specific cut-offs in 6-min walk test, exercise duration and functional capacity
Frailty assessment Explore the optimal strategy for frailty assessment among women with advanced heart failure
Waitlisting prior to heart transplant Identify the optimal waitlist strategy for female patients in the pre-transplant period
Chronic inotrope use Impact of chronic inotropes on sex-based clinical outcomes
Palliative care Explore a sex-specific approach to the use of palliative care interventions
Temporary mechanical circulatory support Evaluate sex-specific differences in the utilization and outcomes of temporary mechanical circulatory support
Anticoagulation strategy in LVAD Explore optimal anticoagulation strategies in male and female LVAD patients
Referral for advanced therapies Evaluate the role of a sex-specific risk stratification strategy in referrals for advanced cardiac therapies
Allocation of advanced therapies Evaluate impact of interventions aimed at reducing inequities in allocation of advanced cardiac therapies

LVAD, left ventricular assist devices.